Analysis consistently highlights that large, well-designed studies like the Lopez-Medina trial demonstrate ivermectin's lack of benefit, employing technical language and referencing DOIs and study flaws, which underscores the high level of interest and engagement in scientific validation. Words such as 'no significant difference,' 'flawed study,' and direct citations reinforce their critical stance, emphasizing the importance of rigorous evidence.
AgreementStrong disagreement
Most discussions emphasize that rigorous clinical trials show ivermectin does not significantly improve COVID-19 symptoms, aligning with the article's conclusion.
InterestHigh interest
Many participants show high interest, referencing multiple large, peer-reviewed studies, detailed statistics, and critique of methodologies.
EngagementHigh engagement
A number of comments analyze specific studies, mention scientific flaws, and question the validity of conflicting claims, indicating deep engagement.
ImpactModerate impact
While recognizing the limited clinical efficacy, some discussions influence public opinion on ivermectin's use, slightly affecting treatment perceptions but with modest immediate impact.
Abstract in brief
This study tested whether ivermectin helps adults with mild COVID-19 recover faster.
The results showed that patients taking ivermectin had a slightly shorter median time to symptom resolution (10 days vs. 12 days), but this difference was not statistically significant.
Overall, the trial found that a 5-day course of ivermectin does not significantly improve recovery time for mild COVID-19 symptoms compared to placebo.
Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution of symptoms." https://t.co/SgPpysyTZX
"...did not result in a lower incidence of medical admission to a hospital..." https://t.co/QI3ix9q1fh
"....did not
May 9, 2024 · 244 likes · 62 shares · 88,318 followersView post →
N
NS
@inParis22122975 · X
4日前に出たばかりのイベルメクチンの論文。
JAMAというかなりインパクトのある雑誌。
残念ながらコロナに対しての効果は認められなかったようです。結構期待していたのですが、JAMAにのってしまうと承認はかなり厳しくなってしまったように思います。
JAMA. 2021 Mar 4. doi: 10.1001/jama.2021.3071
Mar 8, 2021 · 124 likes · 30 shares · 23,184 followersView post →
GB
Gloria Vega Buitrago
@glovega5 · X
@FRANCISCOJZAPPI 2 pueden jugar el juego con diferencia que yo le pongo la direccion del estidio para que lo lea
https://t.co/HfJymDXtAH https://t.co/vWxgwlnIri
Jan 16, 2022 · 24 likes · 2 shares · 579 followersView post →
RF
Rashida Abbas Ferrand
@rashida_abbferr · X
Trial published in JAMA shows NO effect of invermectin on time to symptom resolution in mild COVID19 https://t.co/DfW7F1rqfd
#ivermectin, a broad-spectrum anti-parasite medication, binds Glu-gated ion channels to increases permeability to Cl- ions (PDB ID 5VDH). #clinicaltrials to determine efficacy of ivermectin in treating mild #COVID19 did not support this use. (doi:10.1001/jama.2021.3071) #pdb50 https://t.co/jwSy4WEXIY
This video discusses the effectiveness of various COVID-19 treatments. Dexamethasone was highlighted for its significant reduction in mortality among hospitalized patients, especially those on mechanical ventilation or…
Contributor Don Stader MD discusses ivermectin, a NobelPrize-winning antiparasitic, its safety profile, and overdose risks. The video emphasizes that ivermectin toxicity can cause serious symptoms and that treatment is…
@Jeroen_Rietveld @pjvanerp @ArtsenC @JonaWalk Het is niet de overheid, het is de wetenschap, die zegt dat ivermectine niet werkt bij C 19:
1. Lopez-Medina et alii, 04-03-2021 (400 paticipants)
https://t.co/CnZFXRA4sk
2. Vallejos et alii, 02-07-2021, (IVERCOR-COVID-19; 501 participants)
https://t.co/pdNSnZNUrZ
@sudokuvariante An example of flawed study: protocol mistakes, botched placebo group etc : details here [french] https://t.co/Txr2L8X1ar
https://t.co/etYvSh4MWK
@SearlJk47427 @matthewdmarsden López-Medina, E., et al. (2021). Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA, 325(14), 1426–1435.
@IsDatEchtZo5 @Me_xNL @DrDavidNL @Cornerstar31 Onderzoeken praten we toch over als bewijs⁉️
https://t.co/mniFVdgznD
https://t.co/tGDiobpLSP
https://t.co/Xxp9G58pEK
@IkSendler @BenjaminPDixon @stella_immanuel The DOIs for the studies are 10.1001/jama.2021.3071 (2021) and 10.1001/jama.2022.18590 (2022). Neither study used ivermectin immediately after exposure; both treated patients with symptoms for up to 7 days. The 2021 study used 300 μg/kg daily for 5 days, and the 2022 study used
@fctsMttrLsShttr @denkijidou @DominiekC @HaHaGentherapie @KleberMatte Weet je wat, ik laat je wat concreet bewijs zien.
Hier, een dubbelblinde, placebogecontroleerde studie onder 457 patienten.
Uitkomst: The findings do not support the use of ivermectin for treatment of mild COVID-19
https://t.co/kfP0hgTfkp
Jan 2, 2025 · 2 likes · 1 share · 727 followersView post →
@BorgerPieter Nog steeds niet door dat een stortvloed aan empirisch bewijs in goede klinische studies geen enkel effect van ivermectine aantoont?
https://t.co/3RiLsUD73r
https://t.co/jmCIKjmskR
https://t.co/gFMwqFpNM2
https://t.co/gU2eXJy8wh
Ad hominem reactie graag onder deze feiten ;)
@BorgerPieter Dit is ook de reden dat het negatieve klinische studies regent van ivermectine voor behandeling van covid.
Laat de feiten voor zich spreken.
https://t.co/gU2eXJy8wh
https://t.co/gFMwqFpNM2
https://t.co/3RiLsUD73r
@VPrasadMDMPH Based on made-to-order studies like this
https://t.co/MyHlrfkkQT
and ignoring many of the (much less biased) smaller studies? The peer comments to that JAMA piece of shit are something else.
What was YOUR price?
@ThomasPaine6F0 @Creativologist @Care1168881 @drdenwalker 15/ Lopez-Medina states 'The findings do not support the use of ivermectin for treatment of mild COVID-19' https://t.co/j8QIJOpBo9
@ThomasPaine6F0 @Creativologist @Care1168881 @drdenwalker 7/ Kory (b) Is a twitter post ffs. It references this paper https://t.co/j8QIJOpBo9… Which states https://t.co/tq1ODMZ0pO
@chrismartenson @yoshkapundrick @MonthlySandwich @KamalMokeddem [3] Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to ... https://t.co/3BlOQen72X
[4] Is Ivermectin Effective in Treating COVID-19? - Frontiers https://t.co/BMoIGCn1pC
[5] Effect of Ivermectin on Time to Resolution of Symptoms Among ... https://t.co/Zg8CtTDP4R
[
RT @sudokuvariante: Few weeks later, this study was the first IVM trial published in high IF journal, claiming IVM doesn't work: https://t.…
Jun 21, 2024 · 1 share · 1,526 followersView post →
FS
Fred Stalder
@sudokuvariante · X
Few weeks later, this study was the first IVM trial published in high IF journal, claiming IVM doesn't work: https://t.co/m6spRVFgiz
4/4
Jun 20, 2024 · 2 likes · 1 share · 4,746 followersView post →
B
balkraix
@balkraix · X
@Heritage For some reason, they use the Lopez-medina study as showing a huge benefit despite the study conclusion: https://t.co/O7NwLS8imc https://t.co/RtOCqlW9Jc
Jun 13, 2024 · 1 like · 4,507 followersView post →
BS
Brad Swan
@BradSwan18 · X
@CJane0123 @realXanderXjork Efficacy of Ivermectin on Disease Progression in Patients With COVID-19 (source (https://t.co/PpNIAmOoNl)): This study reports that in a randomized, double-blind, placebo-controlled trial involving 476 patients with mild to moderate COVID-19, those who received ivermectin had a
Which RCT's show ivermectin has efficacy to treat or prevent COVID?
https://t.co/ZAdg72caow
https://t.co/mPcxyGsxuL
https://t.co/xWS6mQEbmv
https://t.co/8Ao4GMkJc9
Jun 5, 2024 · 13 likes · 51,188 followersView post →
CM
Colin MIddleton
@ColinDebunks · X
@CraigKellyPHON Lopez-Medina states 'The findings do not support the use of ivermectin for treatment of mild COVID-19' https://t.co/j8QIJOpBo9
RT @CaulfieldTim: Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution o…
May 17, 2024 · 62 shares · 270 followersView post →
CT
Carolyn Thomas ☮️
@HeartSisters · X
RT @CaulfieldTim: Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution o…
May 13, 2024 · 62 shares · 5,073 followersView post →
A
ArgosyAcres
@argosy68 · X
RT @CaulfieldTim: Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution o…
May 12, 2024 · 62 shares · 251 followersView post →
B
bb
@BeverleyABaird1 · X
RT @CaulfieldTim: Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution o…
May 11, 2024 · 62 shares · 1,117 followersView post →
A
AMK
@Katplns · X
RT @CaulfieldTim: Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution o…
May 11, 2024 · 62 shares · 3,253 followersView post →
D
Demtruth
@EgonACholakian · X
@rustyrockets Ivermectin. Study after study. It doesn't work for COVID. Eg: https://t.co/GSMU7svI06
https://t.co/tiOVIYfpsO
https://t.co/G6g3OH3j4H
https://t.co/uAQeTgcGOp / https://t.co/fhFORk8oPd / https://t.co/BaDoZKeMe3).
https://t.co/MewCWD2J3Z).
May 9, 2024 · 31 shares · 1,492 followersView post →
TC
Timothy Caulfield
@CaulfieldTim · X
Ivermectin. Study after study. It doesn't work for COVID. Eg:
"...did not significantly improve the time to resolution of symptoms." https://t.co/SgPpysyTZX
"...did not result in a lower incidence of medical admission to a hospital..." https://t.co/QI3ix9q1fh
"....did not
May 9, 2024 · 244 likes · 62 shares · 88,318 followersView post →
@WeWillBeFree24 The well designed randomised-controlled trial in question:
Lopez-Medina E., Lopez P., Hurtado I., et al. Effect of ivermectin on time to resolution of symptoms among adults with mild COVID-19. A randomised clinical trial. JAMA. 2021; 325: 1426-1435.
@CramerSez @MikeSington No Evidence of Clinical Benefit
Naggie et al – https://t.co/DyNDTo2AAG
Bramante et al – https://t.co/7hu89cKoHs
Reis et al – https://t.co/d6eTFyBphV
Lopez-Medina et al – https://t.co/aXq7BYx56d
Lim et al – https://t.co/Lcaazia33L
@Geoff35447330 @DrSusanOliver1 Try a peer reviewed study upload to a credible journal next time.
https://t.co/vET2MlifaL
DOI: 10.1056/NEJMoa2115869
doi: 10.1101/2022.06.10.22276252
DOI: 10.1056/NEJMoa2201662
doi:10.1001/jamainternmed.2022.0189
doi: 10.1001/jama.2021.3071.
doi:10.1001/jama.2023.1650
@Geoff35447330 Seeing as you totally ignored the Cochran citation I sent you:
Try these.
DOI: 10.1056/NEJMoa2115869
DOI: 10.1101/2022.06.10.22276252
DOI: 10.1056/NEJMoa2201662
DOI: 10.1001/Jamainternmed.2022.0189
DOI: 10.1001/jama.2021.3071.
DOI:10.1001/jama.2023.1650
@omniadeo @geostylegeo @PierreKory They’re not that hard to find, & statistically show Ivermectin to be no better than placebo. But you’ve made up your mind.
As to future, I will use annual vaccine, likely combined with flu & RSV, as my preventive medicine.
https://t.co/JYZcgeSHOr
So remember all those studies saying Ivermectin didn't work or didn't show any difference in outcomes compared to the placebos? The Placebo used was an Ivermectin Like Therapeutic.
This comes from Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild
Jun 14, 2023 · 1 like · 1,340 followersView post →
@jarad_christian @ZaleskiLuke Here's a scientific question: If I give IVMCT to a group of covid pnts and a placebo to another (and I can't tell who got which) (Double Blinded Randomized Controlled Trials are the best), did it help? Answer -- not really.
https://t.co/2L77WO2Pep
https://t.co/Hal8BtjU6u
@kevinnbass N-95 masking prevents transmission and saves lives.
Covid19 mRNA vaccines have prevented severe Covid19 in Americans, and subsequent hospitalizations and death. In a Double- blind RCT ("Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19",
1/
Mar 25, 2023 · 1 like · 1,489 followersView post →
D
Dugsmok
@dugsmok · X
@_esooMoose_ @rustyrockets López-Medina, E., López, P., Hurtado, I. C., Dávalos, D. M., Ramirez, O., Martinez, E., & Diazgranados, J. A. (2021). Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild : A Randomized Clinical Trial. JAMA, 325(14), 1426-1435. doi: 10.1001/jama.2021.3071
@realCoyotay @headedwest08 @theDetroitJames @abughazalehkat https://t.co/aLu9GtFv3j from the same website. “Ivermectin does not significantly improve symptoms or duration of COVID-19 illness”
@jeffdavismd @dazz_ma_tazz @Mr_Nice_B @ScottAdamsSays @BretWeinstein Start here. If the drug is as amazing as purported, you would expect SOME effect in a randomized controller trial. But there was none https://t.co/UlIqx3Dpyt
@Midilibre Bjr
Ça ne marche pas et ça ne marchera pas CAR
1. l ivermectine est faiblement soluble
2. IVT se lie aux protéines du sang à 75%
la Colombie n'a pas réussi à trouver une efficacité. https://t.co/i4jlpBeec1
Même les internes de l ihu ont expliqué les raisons de leurs opposition
@TeresaW50369178 @paulparrazzilvr @Trainer6161 @NadineGNess No, the one with more than 6 times the participants that showed it did virtually nothing. Or4 any of the dozens of others ones that led to medical experts concluding ivermectin was not the way to go. https://t.co/35xceOO3X4
None of them showed any significant benefit for ivermectin for Covid-19. Here they are:
https://t.co/TxgqfWrcx9
https://t.co/0U5EjPkroz
https://t.co/BV70j93M4q
https://t.co/9Nbvd3C6gR
https://t.co/B5QFtxf0VR
https://t.co/97TMec8dam
https://t.co/3sH1XNQYgt
#週刊女性大失態 ？
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial
成人軽症COVID-19におけるイベルメクチンの症状消失までの時間に対する効果．無作為化臨床試験
https://t.co/5YYBgzoGpO https://t.co/kZ7AG2BPbk
Mar 27, 2022 · 2 likes · 1 share · 449 followersView post →
I
Icarus
@UrSleepyBoi · X
@Earthwanderers @normanswan https://t.co/AcLt7HBaxr Conclusion and relevance: Among adults with mild COVID-19, a 5-day course of ivermectin, compared with placebo, did not significantly improve the time to resolution of symptoms. The findings do not support the use of ivermectin for treatment of mild COVID
Feb 22, 2022 · 16 likes · 3 shares · 34,595 followersView post →
AD
Alexa Scientista Data
@Scientista_Data · X
@Marc_Veld This meta-analysis considers below JAMA study to be good enough to be included.
This JAMA study by LopezMedina has so many flaws (some pointed out on study webpage) that I am truly amazed it was published in JAMA
https://t.co/3NSk5pHJ94
@DelienFlorence @MathieuMolimard @SFPT_fr Essai randomisé contrôlé contre placebo, en double aveugle:
https://t.co/PVy57BZ24V
Pas de différence entre ceux qui ont pris de l'ivermectine et ceux qui n'en ont pas pris.
@TeaTownCowboy @PierreKory Hi Bobby Cowboy! Let me explain one thing. This is just an article from a website. Where is your miraculous double-blind study? Just to help you out, please see these studies with good quality: https://t.co/YaTLRam2Ul
https://t.co/DUoYwjNnxP
@Pajaropolitico @SSaludCdMx Que la pregunten al ilustre y casi benefactor heroico de México: HLG, sacara la información más relevante que esté a modo o si quieren conocer la verdad: doi:10.1001/jama.2021.3071
RT @glovega5: @FRANCISCOJZAPPI 2 pueden jugar el juego con diferencia que yo le pongo la direccion del estidio para que lo lea
https://t.c…
Jan 19, 2022 · 2 shares · 19,146 followersView post →
A
Ashitaka
@Ash_itaka42 · X
@TwoDoser @GidMK Sorry, wrong link: https://t.co/BZuc2ma7Ac
Here are just some results: https://t.co/xaMtUoh181 https://t.co/OoTVt0cg9i
aaaand here's a meta- analysis od them: https://t.co/tngiYER9kf
It. Does. NOT. Work.
RT @glovega5: @FRANCISCOJZAPPI 2 pueden jugar el juego con diferencia que yo le pongo la direccion del estidio para que lo lea
https://t.c…
Jan 16, 2022 · 2 shares · 600 followersView post →
GB
Gloria Vega Buitrago
@glovega5 · X
@FRANCISCOJZAPPI 2 pueden jugar el juego con diferencia que yo le pongo la direccion del estidio para que lo lea
https://t.co/HfJymDXtAH https://t.co/vWxgwlnIri
Jan 16, 2022 · 24 likes · 2 shares · 579 followersView post →
DC
Dale Chapman
@Dale_Chapman_NB · X
@BryanSwarberg @jhoperich @dundeescotia @thedailybeast Facts are on the side of not using Ivermectin.
1 - Ivermectin is NOT effective in treating COVID.
2 - I understand statistics
https://t.co/S3GudTzYaq
https://t.co/wBbFdj7B4f
https://t.co/gOMvHWPYia
https://t.co/ndbpHLhjLT
Even Merck says not to use it:
https://t.co/q3om2SIV1n
@MrWhite0313 @ZachEvans711 @ben_rios82 Sure. PF-07321332 and Molnupiravir are in trials right now, an Ivermectin trial revealed little to no effect in mild cases (doi:10.1001/jama.2021.3071), many other repurposed drugs have been or are being explored with varying results.
@grilla100 @OldMackIsBack There have been several. Some still ongoing. As someone else said, even if the RCTs show no benefit (as seems likely), the grifting ivermectin fans will say the RCTs weren't conducted properly.
https://t.co/87tykfW4mC
https://t.co/C3XqwYbEXG
@LesleyStock5 @TruthTwt @BottomleyFiona @cappsie @kmtildsley @gnomepigface @TeddyFreddy11 @Paulwady @ExtraDouble @BGLTHMND @alumilynn @yeahnaa333 @MentatSword @JaneEOpie @gooner62 @KStateTurk @FreedomSpartan @EDalmayne @Rosewind2007 @latimeralder @kfunk937 @jkellyca @TandT_SEO @ChristRescues @Death_is_final @weaponizedword1 @LynnleeMavakay @qtbeauty @drewawerd1 @natedoromal @djrazorgirl @microRNApro @LaLaRueFrench75 @anniecherokee @AuriaZepherine @Flying_Shadowz @LightControl2 @Takethatdoctors @michaelmina_lab This next RCT study https://t.co/v7Br2yQKAq
There is COI listed. They didn’t begin treatment until 7 days into the illness. It’s supposed to work best early on. Still, the Ivermectin group did slightly better.
Did u discuss any already done?
Like these 2 RCTs showing no stat sig difference btwn ivermectin vs. placebo?
López-Medina E, López P, Hurtado IC, et al. JAMA 2021; 325(14):1426-35.
doi:10.1001/jama.2021.3071
Vallejos J, Zoni R, Aguirre MG, et al. BMC Inf Dis. 2021: 635(21) https://t.co/hCC9PgGc5W
@milaghorayeb Did u discuss any already done?
Like these 2 RCTs showing no stat sig difference btwn ivermectin vs. placebo?
López-Medina E, López P, Hurtado IC, et al. JAMA 2021; 325(14):1426-35.
doi:10.1001/jama.2021.3071
Vallejos J, Zoni R, Aguirre MG, et al. BMC Inf Dis. 2021: 635(21)
Among adults with mild COVID-19, a 5-day course of ivermectin, compared with placebo, did not significantly improve the time to resolution of symptoms. #OVHealthcare #ONEV1
A Randomized Clinical Trial - PubMed https://t.co/riZPMuTwhF
@ciudadano_py @marc_g_wathelet @InCytometry @luomoalto @DrAndrewHill Yes. This study too and 400 patients have been included not 45 with a post-hoc analysis.
https://t.co/HV9ArekpaT
@mollywood I'm a fan. Here's a link to a well-designed trial of Ivermectin in COVID (no significant effect). doi:10.1001/jama.2021.3071 . Many drugs have effects on other conditions. Some anti-depressants may also have a benefit on COVID. The only way to know is to do the studies
@gents84 @rightinthebeach @neontaster Then cite. If you link me an article about Elgazzar et al. you’re blocked.
https://t.co/Wmp0v2k1g9
https://t.co/oZSwgW4kIU
https://t.co/vEHOgZLYa5
https://t.co/eQrF75RBde
https://t.co/RItWtlZss4
https://t.co/vHe9EucT9l
https://t.co/tzMCmeE9TO
https://t.co/uUqvxKEW03
@Hillechien6 @molientjedemol @mannetjemaan @Gerges0576 @ArtsenC Als blijkt dat ivermectine tóch werkt, kan het off-label worden voorgeschreven.
Er is inmiddels echter vrij overtuigend aangetoond dat het niet werkt als behandeling. Zie ook https://t.co/Rvlpa7xz0l. Daarnaast is in vitro veel meer dan veilige dosis nodig om virus te remmen.
Aug 28, 2021 · 1 like · 1,463 followersView post →
@davidpenco1 @enricosacco07 @perchetendenza Pure tu, leggi se sei in grado di capire. https://t.co/KPXEKepLbz
https://t.co/gn3rBIfM50
https://t.co/qLX9HcwnqK
@maragn5 @AlbertoBagnai Forse non capite che i virus a RNA non sono tutti uguali. Leggi va : https://t.co/KPXEKepLbz
https://t.co/gn3rBIfM50
https://t.co/qLX9HcwnqK
@AlbertoBagnai @davidpenco1 Non è che curato un virus li abbiamo curati tutti eh! https://t.co/KPXEKepLbz
https://t.co/gn3rBIfM50
https://t.co/qLX9HcwnqK ecco 3 studi in doppio cieco che dimostrano che l’ivermectina con il COVID non funziona, li legga e smetta di fare disinformazione
@davidpenco1 @enricosacco07 @perchetendenza Questi invece sono studi in doppio cieco..leggili, e intanto chetati tu va! https://t.co/KPXEKepLbz
https://t.co/gn3rBIfM50
https://t.co/qLX9HcwnqK
@georgebest1969 @uragoe "… ivermectin, … did not significantly improve …symptoms. …do not support the use… mild COVID-19, although larger trials may be needed to understand …2021. ‘… Ivermectin… of Symptoms … A Randomized Clinical Trial’. JAMA 325 (14): 1426–35. https://t.co/Ac9rxnvtjf.
@gloSaysGetVaxed @mjsminkey @RonFilipkowski López-Medina E, López P, Hurtado IC, et al. Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(14):1426–1435. doi:10.1001/jama.2021.3071
https://t.co/oEtE00kFCN
@HelenNe02437291 @Deefrancesjones @pjhlaw Why would a RGN suggest pharmaceuticals with no evidence (Ivermectin/HCQ/azithro) while not mention dexamethasone/Tocilizimab/vaccinations? Cureus has no impact factor, here are 3 negative RCTs of ivermectin
https://t.co/KRvtVxMCLG
https://t.co/baPDCUdvb8
https://t.co/CPAQZkSJE0
@ProfTimNoakes @rinmor Just to get things started, here are three of the largest randomised control trials of ivermectin in COVID currently available; quick spoiler no evidence of benefit:
https://t.co/t0ONzNtIxn
https://t.co/5iKwsuzVlM
https://t.co/T4NJpdhvvl
@agargmd You have only given the names of publication sources. Which author's / articles specifically did you use to inform your assertion.
The conflict of interest statement in this article is interesting. https://t.co/BkpNJL9JdO
M.b.t. gebruik van ivermectin als behandeling bij mensen die al ziek zíjn, is inmiddels redelijk overtuigend aangetoond dat het níet werkt. Zie ook https://t.co/Rvlpa7xz0l en https://t.co/srG4YFE5Dv.
Aug 9, 2021 · 3 likes · 1,463 followersView post →
PS. BEFORE SOME CRAY CRAY SUGGESTS IVERMECTIN, 3 OF THE LARGEST RANDOMISED CONTROL TRIALS OF IVERMECTIN IN COVID CURRENTLY AVAILABLE SHOWED NO BENEFIT:
https://t.co/KRvtVxMCLG
https://t.co/baPDCUdvb8
https://t.co/CPAQZkSJE0
@RajaniImamat @LaporCovid @yadismbko @aik_arif @drpriono1 @sociotalker @budhihermanto doi:10.1001/jama.2021.3071
Main2 ke jama network bang, paper ini jadi alasan kenapa sampe sekarang kekeuh ngk di pakek tuh sama ikatan dokter si IVM, ini di test ke manusia, bukan hamster
7-2-2021: In a 501-patient clinical trial just released today from Corrientes, Argentina, bad news for ivermectin for treating COVID-19
https://t.co/L85eSBjoFh
https://t.co/mbnD0pUYuV
https://t.co/DIhEPkNFDz
https://t.co/iSO8hFCV4F
https://t.co/PwrV73SruA
https://t.co/GaRshc7dJh
@sfaysocialist .
IVM trial.
Merck involved indirectly.
Others involved who might like to suppress a useful, non patent, cheap C19 / SC2 therapeutic.
Trialed IVM in a district where IVM was already regularly used by many people.
There were other additional issues.
https://t.co/TqYUBCUqLE
@lcmail2 @HeatherEHeying @Nature @YouTube a) start with "then I heard you say, no... though you are a little squirrely about it tonight..." Then, admire the confidence of the 90% lab leak estimate.
b) No. https://t.co/lKDYTXjE0O
https://t.co/g9hQKF7LIk
https://t.co/67Jejg0MYU
@CezarPrint @joaoires @MomentsBrasil Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial (LÓPEZ-MEDINA et al.,2021)
https://t.co/UWUPvpiZwh
Si l’on peut se demander comment conclure à la non-toxicité dans une maladie d’une molécule étudiée in-vitro, on peut aussi tempérer leur appel à les évaluer, car ils auraient pu mentionner certaines études existantes.
https://t.co/BvdfKXwt0L
Jun 3, 2021 · 8 likes · 1,335 followersView post →
DA
Dr Mushtaq Saif Andrabi
@DrMushtaqSaif1 · X
@Parvaizkoul Sir isn't the sample size of each trial too small to validate it globally when comparing these with this one doi:10.1001/jama.2021.3071
2021/4/13 出版分 twitterでバズった論文 全分野
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
https://t.co/hr2WJK1Y4p
Tweets: 10572
#ivermectin, a broad-spectrum anti-parasite medication, binds Glu-gated ion channels to increases permeability to Cl- ions (PDB ID 5VDH). #clinicaltrials to determine efficacy of ivermectin in treating mild #COVID19 did not support this use. (doi:10.1001/jama.2021.3071) #pdb50 https://t.co/jwSy4WEXIY
RT @AmbrizMau: En adultos con COVID-19 leve, un ciclo de 5 días de IVERMECTINA, comparado con placebo, no mejoró significativamente el tiem…
Mar 5, 2021 · 53 shares · 426 followersView post →
CM
c.mos
@c_mos · X
RT @sikano_tu: イベルメクチンを5日間使用しても、症状消失までの期間は有意に改善せず、軽度患者への使用を支持する結果は得られなかった。だって。
JAMA. March 4, 2021（https://t.co/dxS6JHudqr）
Mar 5, 2021 · 2 shares · 1,245 followersView post →
し
しかのつかさ
@sikano_tu · X
イベルメクチンを5日間使用しても、症状消失までの期間は有意に改善せず、軽度患者への使用を支持する結果は得られなかった。だって。
JAMA. March 4, 2021（https://t.co/dxS6JHudqr）
Mar 5, 2021 · 5 likes · 2 shares · 11,246 followersView post →
にM
にゅろ, MD
@EBNeuro · X
2021/3/4出版分 twitterでバズった論文 全分野
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19
https://t.co/hr2WJK1Y4p
Tweets: 6587
COVID-19に対してイベルメクチンは意味がないというRCT
Quand on veut soigner, on peut - EDITO | FranceSoir
News
JAMA. 2021 Mar 4. doi: 10.1001/jama.2021.3071. Epub ahead of print. 42. Rajter JC, Sherman M., Fatteh N, et al. Use of ivermectin is associated with lower ...
JAMA. Published online March 04, 2021. doi:10.1001/jama.2021.3071 35. Hermine O, Mariette X, Tharaux PL, et al. Effect of tocilizumab vs usual care in ...
Terapijski Protokol Covid 19 - 102021 - Verzija12 | PDF
News
JAMA. Published online March 04, 2021. doi:10.1001/jama.2021.3071 35. Hermine O, Mariette X, Tharaux PL, et al. Effect of tocilizumab vs usual care in ...
SARS CoV-2 Seroprevalence in Selected States of High and Low ...
News
JAMA. 2021;325(14):1426-1435. doi:10.1001/jama.2021.3071 29. Popp M, Stegemann M, Metzendorf MI, et al. Ivermectin for preventing and treating COVID-19.
Terapijski-Protokol-Covid-19 25032021 - Verzija11 | PDF
News
JAMA. Published online March 04, 2021. doi:10.1001/jama.2021.3071 33. Hermine O, Mariette X, Tharaux PL, et al. Effect of tocilizumab vs usual care in ...
kzbmDvJqjJdQR9GfqK65CZs | PDF | Health Sciences | Clinical ...
News
JAMA. 9. Ali MJ, Hanif M, Haider MA, Ahmed MU, Sundas FNU, 2021;325(14):1426. https://doi.org/10.1001/jama.2021.3071. Hirani A, et al. Treatment options for ...
Respondent Broadly and Proactivly Disseminated Inaccurate ...
News
With Mild COVID-19: A Randomized Clinical Trial JAMA. 2021;325(14):1426-1435. doi: 10.1001/jama.2021.3071. Published online March 4, 2021. Bryant, A. et al ...
Hidradenitis suppurativa (HS) is a debilitating, inflammatory skin ...
Facebook
doi:10.1001/jama. 2021.3071 Author Contributions: Drs López-Medina and Ramirez had full access to all of the data in the study and take responsibility for ...
Jama Naggie 2023 Oi 230017 1679344304.92002 | PDF | Clinical ...
News
doi:10.1001/jama.2021.3071 inhibits the replication of SARS-CoV-2 in vitro. ivermectin among patients with Covid-19. N Engl J 6. Bramante CT, Huling JD ...
Wiseman - Support Zanotto | PDF | Type I And Type Ii Errors | Doctor ...
News
JAMA 2021. Epub Mar 4 http://doi.org/10.1001/jama.2021.3071 4. Wiseman D, Kory, P. Possible clustering and/or drug switching confounding obscures up to 56 ...
TC
N
GB
RF
SD
FY
PH
XF
D
R
HM
DV
SD
G
DN
DM
F
S
M
K
NB
CM
UB
TL
AS
F
GW
FS
B
BS
JG
TT
MK
CT
A
B
A
D
A
A
E
TS
KT
MG
RM
FM
FC
JM
HM
KC
RL
AS
FT
O
BP
CS
TM
RK
F
C
SL
W
CE
H
M
L
DK
EP
GK
RP
K
CD
PY
FG
RB
ML
SR
DT
HV
H
MO
DR
KD
YD
MJ
NP
BF
R
AS
J
KC
ST
LR
DM
VM
TS
U
KB
M
M
EP
JM
PA
R
J
KT
TG
Y
O
D
Ð
P
GP
PT
G
N
お
R
AF
よ
議
M
N
N
I
RC
E
S
ｺ
春回
C港
M
J
MS
FS
R
D
AW
A
MF
AP
DC
PA
R
TM
R
AT
F
WL
SA
S
に
TT
SP
CD
M
FL
G
B
BB
JB
DB
O
C
DP
MT
SP
PS
ID
OM
S
MT
PP
FR
OS
E
SM
MB
N
LA
FF
DA
L
M
LE
にM
A
EB
C
BV
G
TG
DB
飴
FB
KA
ゆ
S
二
さ
C
し
ヒ
み
黒猫
ビ
MB
S回
ぽ
CA
A
麻
Mめ
RB
S
K
Y
A
S
M
M
小
K
JY
利
YG
ハ
S
MM
ぴな
JM
CM
し
MV
AL
GG
N
RL
DA
AK
C
MA
ST
V
ER